Delta-Fly Pharma, Inc.
4598.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥5,060 | ¥4,329 | ¥3,411 | ¥3,261 |
| - Cash | ¥339 | ¥1,417 | ¥844 | ¥1,268 |
| + Debt | ¥0 | ¥0 | ¥0 | ¥0 |
| Enterprise Value | ¥4,721 | ¥2,912 | ¥2,567 | ¥1,992 |
| Revenue | ¥0 | ¥0 | ¥0 | ¥300 |
| % Growth | – | – | -100% | – |
| Gross Profit | -¥2 | -¥2 | -¥2 | ¥300 |
| % Margin | – | – | – | 100% |
| EBITDA | -¥1,717 | -¥1,402 | -¥1,324 | -¥960 |
| % Margin | – | – | – | -320% |
| Net Income | -¥1,721 | -¥1,429 | -¥1,329 | -¥967 |
| % Margin | – | – | – | -322.4% |
| EPS Diluted | -195.58 | -198.78 | -234.51 | -178.58 |
| % Growth | 1.6% | 15.2% | -31.3% | – |
| Operating Cash Flow | -¥1,835 | -¥1,280 | -¥1,303 | -¥940 |
| Capital Expenditures | -¥0 | -¥1 | -¥0 | ¥0 |
| Free Cash Flow | -¥1,835 | -¥1,281 | -¥1,303 | -¥940 |